A Pharmacokinetic/Pharmacodynamic Approach to Predict the Cumulative Cortisol Suppression of Inhaled Corticosteroids Bernd MeibohmGünther HochhausHartmut Derendorf OriginalPaper 01 April 1999 Pages: 127 - 147
Mixed Effect Modeling of Sumatriptan Pharmacokinetics During Drug Development: II. From Healthy Subjects to Phase 2 Dose Ranging in Patients Valérie F. CossonEliane Fuseau OriginalPaper 01 April 1999 Pages: 149 - 171
Do Plasma Concentrations Obtained from Early Arterial Blood Sampling Improve Pharmacokinetic/Pharmacodynamic Modeling? Ton M. BeaufortJohannes H. ProostJ. Mark K. H. Wierda OriginalPaper 01 April 1999 Pages: 173 - 190
Construction of an Optimal Destructive Sampling Design for Noncompartmental AUC Estimation Francois VandenhendeMuriel ComblainBruno Boulanger OriginalPaper 01 April 1999 Pages: 191 - 212
Constructing a Prediction Interval for Time to Reach a Threshold Concentration Based on a Population Pharmacokinetic Analysis: An Application to Basiliximab in Renal Transplantation France MentréJohn KovarikChristophe Gerbeau OriginalPaper 01 April 1999 Pages: 213 - 230